Two-for-one molecule could target two key drivers of aggressive childhood cancer 01 May 2019 A group of molecules which each simultaneously target two of the most common genetic faults behind an aggressive form of childhood cancer could lead to a potential new drug for the disease, a new ICR study suggests. Find out more Show/Hide
New study discovers inhibitors of protein linked to the devastating childhood brain cancer DIPG 16 Oct 2018 Scientists at The Institute of Cancer Research, London in collaboration with a team at the Structural Genomics Consortium in Oxford (SGC) have created a new series of compound that could form the basis for drugs that target the devastating childhood brain cancer diffuse intrinsic pontine glioma, or DIPG. Find out more Show/Hide
Scientists build molecule to disrupt cancer protein 16 May 2017 Researchers have designed and built a molecule that blocks the action of a protein linked to tumour development. Find out more Show/Hide